Delivery Order SPE2DB20D3103-SPE2DB22FN2Q6

Award Date 4/5/22
Potential Completion Date 4/6/22
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,200.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KENGREAL 50 MG VIALS, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,309.04, is a Firm Fixed Price Delivery Order for the medical product KENGREAL 50 MG VIALS. The award has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $9,664.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product KENGREAL 50 MG VIALS, with a performance period through April 17, 2024. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $14,678.52 placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the procurement of 4,565,563,515 vials of the medication KENGREAL 50 MG. This IDC, worth up to $999,999,999 and running through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $3,732.25 firm-fixed-price delivery order is for the supply of 4,564,814,393 units of the blood-clotting medication KCENTRA 500 UNIT VIALS. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the supply of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides pharmaceutical products and medical supplies to the U.S. government. The $41,555.96 Delivery Order contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a firm fixed price and an ultimate completion date of October 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,586.57 Delivery Order contract is for pharmaceutical and medical supply products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $11,586.30 issued by the Defense Logistics Agency (DLA). The contract covers the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $18,508.86. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. The award is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN2Q6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,858.56 firm-fixed-price delivery order is for the supply of 4556791245 KENGREAL 50 MG VIALS, with an ultimate completion date of April 6, 2022.

Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

The contract award did not include any set-aside designation, indicating open competition. These contract awards demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.

Generated 2/27/25, 11:15 AM